Jacques B de Kok

2.3k total citations
24 papers, 1.7k citations indexed

About

Jacques B de Kok is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Jacques B de Kok has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Physiology. Recurrent topics in Jacques B de Kok's work include Bladder and Urothelial Cancer Treatments (9 papers), Cancer Research and Treatments (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Jacques B de Kok is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Cancer Research and Treatments (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Jacques B de Kok collaborates with scholars based in Netherlands, United States and Sweden. Jacques B de Kok's co-authors include Dorine W. Swinkels, Rian Roelofs, B. Giesendorf, Jack A. Schalken, Lambertus A. Kiemeney, Tilly Aalders, Paul N. Span, Daphne Hessels, Gerald W. Verhaegh and Jeroen L. A. Pennings and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Jacques B de Kok

24 papers receiving 1.6k citations

Peers

Jacques B de Kok
Hovsep Melkonyan United States
David Baunoch United States
Jingde Zhu China
Zheng Ge China
Arline D. Deitch United States
Angela Costantino Italy
Daniela Giachino Italy
José M. Izquierdo Spain
Hovsep Melkonyan United States
Jacques B de Kok
Citations per year, relative to Jacques B de Kok Jacques B de Kok (= 1×) peers Hovsep Melkonyan

Countries citing papers authored by Jacques B de Kok

Since Specialization
Citations

This map shows the geographic impact of Jacques B de Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques B de Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques B de Kok more than expected).

Fields of papers citing papers by Jacques B de Kok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques B de Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques B de Kok. The network helps show where Jacques B de Kok may publish in the future.

Co-authorship network of co-authors of Jacques B de Kok

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques B de Kok. A scholar is included among the top collaborators of Jacques B de Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques B de Kok. Jacques B de Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oostendorp, M. van, et al.. (2019). Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer. Practical Laboratory Medicine. 17. e00146–e00146. 3 indexed citations
2.
Schultz, Iman J., Lambertus A. Kiemeney, Rian Roelofs, et al.. (2007). The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.. PubMed. 27(2). 1025–30. 4 indexed citations
3.
Schultz, Iman J., Jacques B de Kok, J. Alfred Witjes, et al.. (2007). Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.. PubMed. 27(2). 1051–8. 7 indexed citations
4.
Schultz, Iman J., Kenneth Wester, Huub Straatman, et al.. (2006). Prediction of recurrence in Ta urothelial cell carcinoma by real‐time quantitative PCR analysis: A microarray validation study. International Journal of Cancer. 119(8). 1915–1919. 19 indexed citations
5.
Schultz, Iman J., J. Alfred Witjes, Dorine W. Swinkels, & Jacques B de Kok. (2006). Bladder cancer diagnosis and recurrence prognosis: Comparison of markers with emphasis on survivin. Clinica Chimica Acta. 368(1-2). 20–32. 31 indexed citations
6.
Schultz, Iman J., Kenneth Wester, Huub Straatman, et al.. (2006). Gene Expression Analysis for the Prediction of Recurrence in Patients with Primary Ta Urothelial Cell Carcinoma. European Urology. 51(2). 416–423. 23 indexed citations
7.
Schultz, Iman J., Lambertus A. Kiemeney, J. Alfred Witjes, et al.. (2005). CDC91L1 (PIG‐U) mRNA expression in urothelial cell carcinomas. International Journal of Cancer. 116(2). 282–284. 6 indexed citations
8.
Kok, Jacques B de, Rian Roelofs, B. Giesendorf, et al.. (2004). Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Laboratory Investigation. 85(1). 154–159. 471 indexed citations
9.
Schultz, Iman J., Lambertus A. Kiemeney, Herbert F.M. Karthaus, et al.. (2004). Survivin mRNA Copy Number in Bladder Washings Predicts Tumor Recurrence in Patients with Superficial Urothelial Cell Carcinomas. Clinical Chemistry. 50(8). 1425–1428. 34 indexed citations
10.
Verhaegh, Gerald W., Jacques B de Kok, Daphne Hessels, Frank Smit, & Jack A. Schalken. (2003). DD3, a very sensitive and specific merker to detect prostate tumors. Reply to: Gandino O, Santulli M, Cardillo MR, Stigliano A, Toscano V. Correspondence re: J.B. de Kok et al.. Cancer Research. 63. 4748–4749. 2 indexed citations
11.
Spencer, Kevin, Jacques B de Kok, & Dorine W. Swinkels. (2003). Increased total cell‐free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. Prenatal Diagnosis. 23(7). 580–583. 28 indexed citations
12.
Schultz, Iman J., Lambertus A. Kiemeney, J.A. Witjes, et al.. (2003). Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.. PubMed. 23(4). 3327–31. 52 indexed citations
13.
Kok, Jacques B de, Erwin T. Wiegerinck, B. Giesendorf, & Dorine W. Swinkels. (2002). Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Human Mutation. 19(5). 554–559. 110 indexed citations
14.
Kok, Jacques B de, Gerald W. Verhaegh, Rian Roelofs, et al.. (2002). DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.. PubMed. 62(9). 2695–8. 478 indexed citations
15.
Kok, Jacques B de, Jack A. Schalken, Tilly Aalders, et al.. (2000). Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. International Journal of Cancer. 87(2). 217–220. 2 indexed citations
16.
Kok, Jacques B de, et al.. (2000). Quantification of hTERT mRNA and Telomerase Activity in Bladder Washings of Patients with Recurrent Urothelial Cell Carcinomas. Clinical Chemistry. 46(12). 2003–2007. 17 indexed citations
17.
Kok, Jacques B de, Theo J. M. Ruers, Goos N.P. van Muijen, et al.. (2000). Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues. Clinical Chemistry. 46(3). 313–318. 62 indexed citations
18.
Kok, Jacques B de, Albert J.W. Zendman, Theo J. M. Ruers, et al.. (1999). Real-time hTERT quantification: a promising telomerase-associated tumor marker.. PubMed. 79(7). 911–2. 17 indexed citations
19.
Kok, Jacques B de, Jan C.M. Hendriks, Wouter W. van Solinge, et al.. (1998). Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods. Clinical Chemistry. 44(10). 2201–2204. 53 indexed citations
20.
Kok, Jacques B de, Wouter W. van Solinge, T.J.M. Ruers, et al.. (1997). Detection of tumour DNA in serum of colorectal cancer patients. Scandinavian Journal of Clinical and Laboratory Investigation. 57(7). 601–604. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hovsep Melkonyan Breakdown of academic impact, for papers by David Baunoch Breakdown of academic impact, for papers by Jingde Zhu Breakdown of academic impact, for papers by Zheng Ge Breakdown of academic impact, for papers by Arline D. Deitch Breakdown of academic impact, for papers by Angela Costantino Breakdown of academic impact, for papers by Daniela Giachino Breakdown of academic impact, for papers by José M. Izquierdo
Rankless by CCL
2026